Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.
Shi M, Pang L, Zhou H, Mo S, Sheng J, Zhang Y, Liu J, Sun D, Gong L, Wang J, Zhuang W, Huang Y, Chen Z, Zhao Y, Li J, Huang Y, Yang Y, Fang W, Zhang L.
Shi M, et al. Among authors: sheng j.
Lung Cancer. 2024 May 9;192:107818. doi: 10.1016/j.lungcan.2024.107818. Online ahead of print.
Lung Cancer. 2024.
PMID: 38763102